Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study-Reference-Cited by-同舟云学术

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

Published:2018-05 Issue:5 Volume:17 Page:416-422
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Fang Ton,Al Khleifat Ahmad,Meurgey Jacques-Henri,Jones Ashley,Leigh P Nigel,Bensimon Gilbert,Al-Chalabi Ammar

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference29 articles.

1. Amyotrophic lateral sclerosis: moving towards a new classification system;Al-Chalabi;Lancet Neurol,2016

2. Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis;Fogh;JAMA Neurol,2016

3. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis;Chio;J Neurol Neurosurg Psychiatry,2015

4. A proposed staging system for amyotrophic lateral sclerosis;Roche;Brain,2012

5. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III);Cedarbaum;J Neurol Sci,1999

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcranial static magnetic stimulation for amyotrophic lateral sclerosis: a bicentric, randomised, double-blind placebo-controlled phase 2 trial;The Lancet Regional Health - Europe;2024-10

2. The WFS1‐ZnT3‐Zn²⁺ Axis Regulates the Vicious Cycle of Obesity and Depression;Advanced Science;2024-09-11

3. Anodal tsDCS restores the structure and function of the disrupted proprioceptive Ia synapses on spinal motoneurons in the SOD1 G93A mouse model of ALS;2024-08-06

4. Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile;Pharmaceutics;2024-07-26

5. Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data;Journal of Racial and Ethnic Health Disparities;2024-07-08